All Pharmaceutical Articles
  • ‘PEACE’ and ‘LOVE’ replace outdated soft tissue…

    Heidi Dawson Sports & Fitness

    When it comes to soft tissue injury treatment, you have most likely have heard of RICE; standing for rest, ice, compression, and elevation. You may well have also heard of PRICE, where the additional P stands for protection. This was then updated to POLICE around 2012, replacing rest with optimal loading, alongside protection and the longstanding ice, compression and elevation. But two new acronyms are doing the rounds, proposed last month on the British Journal of Sports Medicine’s blog.

  • Court’s blockage of liver-sharing policy sparks conflict

    Chelsea Adams Medical & Allied Healthcare

    A plan intended to correct regional inequities among liver transplant recipients is on hold after a lawsuit to block its implementation was filed by transplant centers in the South and Midwest. The United Network for Organ Sharing (UNOS) has worked to create a new way of distributing organs since 2012. The plan calls for the most critically ill patients within a set geographic parameter to receive organs first. For example, if a liver became available in Nashville, the sickest patient within a 500 nautical-mile radius would receive it.

  • Can dentists help with the opioid epidemic? Webinar set for June 19

    Tammy Hinojos Oral & Dental Healthcare

    With the nation’s first opioid lawsuit by a state (Oklahoma) against big pharma underway last week and expected to last through the summer, even more light is being cast on the country’s growing opioid epidemic. The American Dental Association is doing its part to educate and equip dentists in a variety of ways. On June 19, the ADA is hosting a webinar on opioid use disorder and how dentists can help prevent patients from developing it. Perhaps most importantly, participants will also learn how to treat acute dental-related pain without using opioids.

  • Business group believes Medicare for All healthcare is best

    Seth Sandronsky Medical & Allied Healthcare

    Small- and midsize-business owners do not like the current healthcare system. Just ask Dylan Dusseault, executive director of the Business Initiative for Health Policy (BIHP), in Washington, D.C. "Business owners want out of providing healthcare," he said via email to MultiBriefs. "The employer-sponsored system isn't working for them or their workers, but they're all being held hostage by rising premiums and out-of-pocket costs. BIHP was created to advocate for what business owners actually need: A Medicare for All healthcare system."

  • Pew report: Provider demand for accurate patient matching is high

    Scott E. Rupp Healthcare Administration

    The Pew Charitable Trusts is concerned with the ability to accurately match patients to their health records. According to healthcare providers surveyed, match rates are "far below the desired level for effective data exchange," said researchers at Pew, which collaborated with eHealth Collaborative on the report. Patient matching is the comparing of data from different health IT systems to verify if data sources match and belong to the same patient. Matching data completes the patient’s health history and medical care record. If data matches, that patient’s records are combined to eliminate duplication and confusion.

  • Newly approved device to help increase access to suitable lungs for transplant

    Lynn Hetzler Medical & Allied Healthcare

    On April 26, the U.S. Food and Drug Administration (FDA) approved a new device that may increase access to more lungs for transplant. The new Xvivo Perfusion System (XPS) is a type of ex vivo lung perfusion (EVLP) therapy, which can temporarily ventilate and pump preservation solution through lungs. The process can increase the percentage of lung transplants by allowing transplant teams to identify better quality lung grafts that would have been otherwise rejected for transplantation in the past.

  • Randstad Sourceright discusses healthcare’s tightening talent market

    Terri Williams Healthcare Administration

    First, the good news: life expectancies are rising, 10,000 baby boomers are retiring every day (which provides jobs for other workers and gives boomers an opportunity to enjoy their golden years), and the life sciences and healthcare sector is projected to grow by 5.4% annually, outpacing global GDP. Now, the bad news: According to Randstad Sourceright's 2019 Talent Trends survey, 85% of human capital and C-suite leaders in the life sciences and healthcare sector say talent scarcity is one of their greatest concerns.

  • Patriarchy and healthcare: A dying zeitgeist

    Keith Carlson Medical & Allied Healthcare

    Since time immemorial, men have dominated medicine. Nurses were historically viewed as subservient laborers who followed orders and carried no sense of personal or professional agency; in that same vein, female physicians were less numerous and not readily recognized for their contributions by their male peers. In many aspects of our lives, this paradigm is shifting for the better, and that same change is also underway in the healthcare sphere.

  • Study: Only 1.5% of those at high risk of opioid overdose receive a prescription…

    Lynn Hetzler Medical & Allied Healthcare

    The vast majority of people who are at high risk of opioid overdose are not prescribed the naloxone they may one day need to save their lives, according to the results of a new study published in JAMA. In fact, the researchers found that only about 1.5% of high-risk patients receive such a prescription, despite multiple opportunities. Sarah Follman and associates from the University of Chicago performed a retrospective study in which they analyzed data from the Truven Health MarketScan Research Database.

  • Mefloquine: A personal perspective

    Roy Phillips Law Enforcement, Defense & Security

    If you’ve deployed to Iraq or Afghanistan, especially in the early days of Operation Iraqi Freedom and Operation Enduring Freedom, you were probably prescribed mefloquine. For those of you who are unfamiliar with the drug, it is an anti-malarial with some odd and obvious side effects. The drug, a white pill, was to be ingested every Monday morning for the duration of the deployment, followed by a two-week-long daily dose of primaquine. Earlier this year, the VA established a committee to study the long-term effects of mefloquine toxicity.